Company news
Shanghai Raas Blood Products Co., Ltd. Class A (SZSE:002252) news
Shanghai Raas Blood Products Co., Ltd. Class A news releases on 6ix. Latest, Apr 29, 2026: Shanghai RAAS Blood Products: Q1 2026 saw revenue and profit…
Press releases & updates
Shanghai RAAS Blood Products: Q1 2026 saw revenue and profit decline sharply year-over-year, but sequential improvement emerged
April 28, 2026
Shanghai RAAS Blood Products Q1 Net Profit Down 44.2% Y/Y
April 28, 2026
Shanghai RAAS Blood Products: Revenue and profit declined, but plasma expansion and innovation drive future growth
March 27, 2026
Shanghai RAAS Blood Products 2025 Net Profit Down 28.1%
March 26, 2026
Shanghai RAAS Blood Products: Net profit dropped 26% on flat revenue, with major buybacks and clinical trial advances
October 28, 2025
Shanghai RAAS Blood Products Q3 Net Profit Down 26.2% Y/Y
October 27, 2025
Shanghai RAAS Blood Products: Revenue and profit fell, but cash flow and strategic expansion strengthened future prospects
August 29, 2025
Shanghai RAAS Blood Products: Net profit fell 25% in Q1 2025, but strategic acquisitions and buybacks support future growth
April 28, 2025
Shanghai RAAS Blood Products: 2024 saw robust profit growth, Haier control, and strategic expansion for Shanghai RAAS
April 17, 2025
Shanghai RAAS Blood Products: Revenue and profit rose in Q3 2024 as Haier Group took control and R&D advanced
October 29, 2024
Shanghai RAAS Blood Products: H1 2024 revenue up 9.02% YoY, Haier Group now controls Shanghai RAAS
August 26, 2024